Term
|
Definition
Take first thing tomorrow
|
|
|
Term
|
Definition
Take first thing tomorrow
if >1 day, skip dose for week
Continue on original schedule |
|
|
Term
|
Definition
if >7 days to next dose, take next morning
go back to original schedule
Don't take >1 per 7 days. |
|
|
Term
A patient on Bisphosphonates can't sit/stand for 30 minutes |
|
Definition
|
|
Term
Counseling for Bisphosphonates
(Alendronate & Risedronate) |
|
Definition
- 30 minutes before food/drinks
- with 8oz water
- Sit/stand for 30 minutes
- No other drugs for 60 mins.
|
|
|
Term
|
Definition
- Climera
- Orthoest
- Premarin
- Estratab
|
|
|
Term
Estrogen + Progesterin therapy (HT) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Bisphosphonate (PO)
10mg QD
CRCL <35 |
|
|
Term
|
Definition
(Actonel) Bisphosphonate (PO)
5mg QD |
|
|
Term
|
Definition
(Boniva) Bisphosphonate (PO/IV)
2.5mg QD
60 minutes |
|
|
Term
|
Definition
(Reclast) Bisphosphonate (IV)
QY |
|
|
Term
|
Definition
(Evista) Estrogen agonist/antagonist (PO)
Risk: Blood clot
|
|
|
Term
|
Definition
(Fortical) Nasal
5 year post menopause
|
|
|
Term
|
Definition
Binds to RANKL (SC)
Osteoclast apoptosis
|
|
|
Term
|
Definition
Recombinant PTH Builds bone (SC)
Post menopause + highest risk
2 years max, osteosarcoma
|
|
|
Term
|
Definition
- women ≥65 & Men ≥70
- Postmenopausal/Risk/Fracture ≥50
- Bone degenerative med
|
|
|
Term
T scores
- Normal
- Osteopenic
- Osteoperotic
- Severe:
|
|
Definition
- Normal: -1 or above
- Osteopenic: -2 to -2.5
- Osteoperotic: < -2.5
- Severe: -2.5 + fracture history
|
|
|
Term
|
Definition
Below average: ≤-2
Within expected: >-2 |
|
|
Term
25(OH) D
- Deficient
- Insufficient
- Normal
|
|
Definition
- Deficient: ≤20
- Insufficient: 21-29
- Normal: ≥30
|
|
|
Term
Daily amount for adults over 50
Calcium |
|
Definition
|
|
Term
Daily amount for adults over 50
Vitamin D |
|
Definition
|
|
Term
|
Definition
- Ca
- D vitamin
- Exercise
- Fall prevention
- Good habbits
|
|
|
Term
|
Definition
|
|
Term
|
Definition
1000 = 210
Citrical
(Food not important) |
|
|